We provide you with 20 years of free, institutional-grade data for PHGE stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of PHGE. Explore the full financial landscape of PHGE stock.
| Reported Date | CIK | Ticker | Type |
|---|
BiomX Inc(NYSE MKT:PHGE) 
BiomX Inc., a clinical stage company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary scler...
Website: http://www.biomx.com
Founded: 2015
Full Time Employees: 73
CEO: Jonathan Eithan Solomon
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about PHGE stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.